Nuclear therapy in thyroid diseases

Oral administration of I-131-sodiumiodide is a commonly accepted procedure for treatment of benign and malignant thyroid diseases since the 1940’s (8). Today, approximately 60.000 patients are treated with radioiodine in Germany; the majority because of benign thyroid diseases and a minority of 5-10% because of thyroid cancer.